Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goodship

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Nature Genetics|October 15, 1998
Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouseD Morgan, L Turnpenny, J Goodship, et al.
Journal of the American Society of Nephrology : JASN|February 23, 2013
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotypeElena Bresin, Erica Rurali, Jessica Caprioli, et al.
Plos Genetics|March 21, 2007
Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndromePeter F Zipfel, Matthew Edey, Stefan Heinen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 23, 2013
Genotype/phenotype correlations in complement factor H deficiency arising from uniparental isodisomyValerie Wilson, Rebecca Darlay, William Wong, et al.
Journal of the American Society of Nephrology : JASN|December 5, 2009
Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric refluxHeather J Cordell, Rebecca Darlay, Pimphen Charoen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2015
The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathiesE H Phillips, J P Westwood, V Brocklebank, et al.
Blood Advances|January 4, 2018
Use of the complement inhibitor Coversin to treat HSCT-associated TMATimothy H J Goodship, Fernando Pinto, Wynn H Weston-Davies, et al.
Blood|October 29, 2009
Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndromeIain Moore, Lisa Strain, Isabel Pappworth, et al.
Journal of Medical Genetics|September 28, 2014
Factors determining penetrance in familial atypical haemolytic uraemic syndromeFrancis H Sansbury, Heather J Cordell, Coralie Bingham, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2003
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndromeAnna Richards, Elizabeth J Kemp, M Kathryn Liszewski, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Nature Genetics|October 15, 1998
Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouseD Morgan, L Turnpenny, J Goodship, et al.
Journal of the American Society of Nephrology : JASN|February 23, 2013
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotypeElena Bresin, Erica Rurali, Jessica Caprioli, et al.
Plos Genetics|March 21, 2007
Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndromePeter F Zipfel, Matthew Edey, Stefan Heinen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 23, 2013
Genotype/phenotype correlations in complement factor H deficiency arising from uniparental isodisomyValerie Wilson, Rebecca Darlay, William Wong, et al.
Journal of the American Society of Nephrology : JASN|December 5, 2009
Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric refluxHeather J Cordell, Rebecca Darlay, Pimphen Charoen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2015
The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathiesE H Phillips, J P Westwood, V Brocklebank, et al.
Blood Advances|January 4, 2018
Use of the complement inhibitor Coversin to treat HSCT-associated TMATimothy H J Goodship, Fernando Pinto, Wynn H Weston-Davies, et al.
Blood|October 29, 2009
Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndromeIain Moore, Lisa Strain, Isabel Pappworth, et al.
Journal of Medical Genetics|September 28, 2014
Factors determining penetrance in familial atypical haemolytic uraemic syndromeFrancis H Sansbury, Heather J Cordell, Coralie Bingham, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2003
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndromeAnna Richards, Elizabeth J Kemp, M Kathryn Liszewski, et al.
Pageof 14